Department of Neurology, University of Pittsburgh, Pittsburgh, PA USA.
Department of Neurology, Stanford University, Palo Alto, CA USA.
J Stroke Cerebrovasc Dis. 2021 Jun;30(6):105749. doi: 10.1016/j.jstrokecerebrovasdis.2021.105749. Epub 2021 Mar 27.
While telestroke 'hub-and-spoke' systems are a well-established model for improving acute stroke care at spoke facilities, utility beyond the hyperacute phase is unknown. In patients receiving intravenous thrombolysis via telemedicine, care at spoke facilities has been shown to be associated with longer length of stay and worse outcomes. We sought to explore the impact of ongoing stroke care by a vascular neurologist via telemedicine compared to care provided by local neurologists.
A network spoke facility protocol was revised to pilot telestroke consultation with a hub vascular neurologist for all patients presenting to the emergency department with ischemic stroke or transient ischemic attack regardless of time since onset or severity. Subsequent telestroke rounds were performed for patients who received initial telestroke consultation. Key outcome measures were length of stay, 30-day readmission and mortality and 90-day mRS. Results during the pilot (post-cohort) were compared to the same hospital's previous outcomes (pre-cohort).
Of 257 enrolled patients, 67% were in the post-cohort. Forty percent (69) of the post-cohort received an initial telestroke consult. In spoke-retained patients followed by telestroke rounds (55), median length of stay decreased by 0.8 days (P = 0.01). Readmission and mortality rates did not differ significantly between groups (19.5 vs. 9.1%, P = 0.14 and 3.9 vs. 3.6%, P = 1, respectively). The favorable functional outcome rate was similar between groups (47.3% vs 65.9%, P = 0.50).
Longitudinal stroke care via telestroke may be economically viable through length of stay reduction. Randomized prospective studies are needed to confirm our findings and further investigate this model's potential benefits.
虽然远程卒中“中心-辐射”系统是改善辐射状卒中治疗的成熟模式,但在超急性期之外的效用尚不清楚。在通过远程医疗接受静脉溶栓治疗的患者中,辐射状卒中治疗与住院时间延长和预后不良有关。我们试图探索通过远程医疗由血管神经科医生提供持续卒中治疗与由当地神经科医生提供治疗相比的影响。
修订了网络辐射状卒中治疗中心的方案,为所有因缺血性卒中和短暂性脑缺血发作就诊于急诊室的患者(无论发病时间长短或严重程度如何)提供与卒中中心血管神经科医生进行远程卒中会诊。对接受初始远程卒中会诊的患者进行后续远程卒中会诊。主要结局测量指标为住院时间、30 天再入院率和死亡率以及 90 天 mRS。试点(后队列)期间的结果与同一医院之前的结果(前队列)进行比较。
257 名入组患者中,67%在后队列。后队列中有 40%(69 例)接受了初始远程卒中会诊。在接受远程卒中随访的辐射状卒中保留患者(55 例)中,中位住院时间缩短了 0.8 天(P=0.01)。两组之间的再入院率和死亡率无显著差异(19.5%比 9.1%,P=0.14 和 3.9%比 3.6%,P=1)。两组之间的良好功能结局率相似(47.3%比 65.9%,P=0.50)。
通过远程卒中进行纵向卒中治疗可能通过缩短住院时间而具有经济可行性。需要进行随机前瞻性研究来证实我们的发现,并进一步研究这种模式的潜在益处。